| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles (L.M., J.J.J.V.D., G.S., M.B., G.V., S.C.), Campus Erasme, B-1070 Brussels, Belgium; Service de Génétique Médicale (G.S., G.V.), Hôpital Erasme, B-1070 Brussels, Belgium; Department of Endocrinology (L.M.), University of Pisa, 54126 Pisa, Italy; Institute of Endocrine Sciences (M.B.), University of Milan, Istituto Auxologico Italiano Istituto di Ricovero e Cura a Carattere Scientifico, Milan 20145, Italy; Institut National de la Santé et de la Recherche Médicale Equipe Mixte U0018 (P.R.), Angers 49035, France; Molecular Genetics and Bioinformatics (E.J.D., K.M.-W.), Integrated DNA Technologies, Coralville, Iowa 52241; and Laboratori de Medicina Computacional (L.P.), Unitat de Bioestadística and Institut de Neurociències, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain
Address all correspondence and requests for reprints to: Dr. Sabine Costagliola, IRIBHM, Université Libre de Bruxelles, Campus Erasme, Route de Lennik 808, B-1070 Brussels. E-mail: scostag{at}ulb.ac.be.
Recently, three naturally occurring mutations in the serpentine region of the FSH receptor (FSHr) (D567N and T449I/A) have been identified in three families with spontaneous ovarian hyperstimulation syndrome (OHSS). All mutant receptors displayed abnormally high sensitivity to human chorionic gonadotropin and, in addition, D567N and T449A displayed concomitant increase in sensitivity to TSH and detectable constitutive activity. In the present study, we have used a combination of site-directed mutagenesis experiments and molecular modeling to explore the mechanisms responsible for the phenotype of the three OHSS FSHr mutants. Our results suggest that all mutations lead to weakening of interhelical locks between transmembrane helix (TM)-VI and TM-III, or TM-VI and TM-VII, which contributes to maintaining the receptor in the inactive state. They also indicate that broadening of the functional specificity of the mutant FSHr constructs is correlated to their increase in constitutive activity. This relation between basal activity and functional specificity is a characteristic of the FSHr, which is not shared by the other glycoprotein hormone receptors. It leads to the interesting suggestion that different pathways have been followed during primate evolution to avoid promiscuous stimulation of the TSHr and FSHr by human chorionic gonadotropin. In the hFSHr, specificity would be exerted both by the ectodomain and the serpentine portion.
This article has been cited by other articles:
![]() |
S. R. Soares, R. Gomez, C. Simon, J. A. Garcia-Velasco, and A. Pellicer Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome Hum. Reprod. Update, April 2, 2008; (2008) dmn008v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Feng, T. Muller, D. Mizrachi, F. Fanelli, and D. L. Segaloff An Intracellular Loop (IL2) Residue Confers Different Basal Constitutive Activities to the Human Lutropin Receptor and Human Thyrotropin Receptor through Structural Communication between IL2 and Helix 6, via Helix 3 Endocrinology, April 1, 2008; 149(4): 1705 - 1717. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhang, Y.-X. Tao, G. L. Ryan, X. Feng, F. Fanelli, and D. L. Segaloff Intrinsic Differences in the Response of the Human Lutropin Receptor Versus the Human Follitropin Receptor to Activating Mutations J. Biol. Chem., August 31, 2007; 282(35): 25527 - 25539. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Ryan, X. Feng, C. B. d'Alva, M. Zhang, B. J. Van Voorhis, E. M. Pinto, A. E. F. Kubias, S. R. Antonini, A. C. Latronico, and D. L. Segaloff Evaluating the Roles of Follicle-Stimulating Hormone Receptor Polymorphisms in Gonadal Hyperstimulation Associated with Severe Juvenile Primary Hypothyroidism J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2312 - 2317. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kleinau, M. Brehm, U. Wiedemann, D. Labudde, U. Leser, and G. Krause Implications for Molecular Mechanisms of Glycoprotein Hormone Receptors Using a New Sequence-Structure-Function Analysis Resource Mol. Endocrinol., February 1, 2007; 21(2): 574 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F. VLAHOS and O. GREGORIOU Prevention and Management of Ovarian Hyperstimulation Syndrome Ann. N.Y. Acad. Sci., December 1, 2006; 1092(1): 247 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bonomi, M. Busnelli, L. Persani, G. Vassart, and S. Costagliola Structural Differences in the Hinge Region of the Glycoprotein Hormone Receptors: Evidence from the Sulfated Tyrosine Residues Mol. Endocrinol., December 1, 2006; 20(12): 3351 - 3363. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Van Durme, F. Horn, S. Costagliola, G. Vriend, and G. Vassart GRIS: Glycoprotein-Hormone Receptor Information System Mol. Endocrinol., September 1, 2006; 20(9): 2247 - 2255. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Allan, A. Garcia, J. Spaliviero, M. Jimenez, and D. J. Handelsman Maintenance of Spermatogenesis by the Activated Human (Asp567Gly) FSH Receptor During Testicular Regression Due to Hormonal Withdrawal Biol Reprod, May 1, 2006; 74(5): 938 - 944. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. De Leener, L. Montanelli, J. Van Durme, H. Chae, G. Smits, G. Vassart, and S. Costagliola Presence and Absence of Follicle-Stimulating Hormone Receptor Mutations Provide Some Insights into Spontaneous Ovarian Hyperstimulation Syndrome Physiopathology J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 555 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Costagliola, E. Urizar, F. Mendive, and G. Vassart Specificity and promiscuity of gonadotropin receptors Reproduction, September 1, 2005; 130(3): 275 - 281. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Urizar, S. Claeysen, X. Deupi, C. Govaerts, S. Costagliola, G. Vassart, and L. Pardo An Activation Switch in the Rhodopsin Family of G Protein-coupled Receptors: THE THYROTROPIN RECEPTOR J. Biol. Chem., April 29, 2005; 280(17): 17135 - 17141. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |